#materialscience

Research, development and commercial applications of advanced flexible materials.

Recent Articles

White Paper: Bridging the Gap from Batch to Continuous Bioprocessing

Abstract

For years, traditional batch manufacturing has dominated the biopharma industry. Recently, however, continuous bioprocessing has gained traction among biopharma manufacturers. Below is a look at some of the key differences between these two types of bioprocessing and the resources required for each. Finally, this paper will examine the ways that industry regulations have adapted to the advent of continuous bioprocessing and the ways that continuous production has impacted the single-use market.

Read More
 0

White paper: FDA Regulated Sterilization Methods

The FDA regulates four critical forms of sterilization: autoclave, dry heat, ethylene oxide, and irradiation. Irradiation includes both gamma ray and electron beam methods. While there are other forms of sterilization, including hydrogen peroxide, high intensity light, and sound waves, these methods are not regulated or approved for use by the FDA at this time. Appropriate, FDA-approved sterilization methods ensure that products are consumable, healthier, and safer for everyone who uses them.

Read More
 0

White Paper: MedTech Supply Chain Strategies

Read More
 0

Application of Molecularly Imprinted Polymers in POC Diagnostics

In Brief

Standard disposable point-of-care diagnostic (POCD) devices are making a positive impact on patient-based healthcare settings worldwide. These devices are convenient and economical, and they provide rapid results. Both clinicians and patients use them to diagnose a range of conditions.

But in certain situations, these diagnostic devices have limitations.

Read More
 0

6 Filtration Challenges in Downstream Biopharmaceutical Production

In Brief

Membranes and membrane processes are efficient filtration tools in the manufacturing of biopharmaceutical products. These tools continue to evolve in response to new therapies and processing methods. The membranes used in separation and purification are beginning to play an even more important role as market demand for monoclonal antibodies (mAbs) and other gene and cell culture therapies have expanded in recent years. The global mAb therapeutics market is projected to grow from almost US$ 95.6 billion in 2017 to US$ 174.2 billion by 2026.

Read More
 0